527
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Pulmonary Valve Stenosis: From Diagnosis to Current Management Techniques and Future Prospects

, , , & ORCID Icon
Pages 379-390 | Received 28 Mar 2023, Accepted 23 Jun 2023, Published online: 30 Jun 2023

References

  • Van der linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241–2247. doi:10.1016/j.jacc.2011.08.025
  • Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American heart association task force on clinical practice guidelines. Circulation. 2019;139(14):e637–e97. doi:10.1161/CIR.0000000000000602
  • Odenwald T, Taylor AM. Pulmonary valve interventions. Expert Rev Cardiovasc Ther. 2011;9(11):1445–1457. doi:10.1586/erc.11.150
  • Shaddy REP, Feltes DJ, Cetta TF. Moss and Adams’ heart disease in infants, children, and adolescents: including the fetus and young adult. JAMA. 2022;2022:1.
  • Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563–645. doi:10.1093/eurheartj/ehaa554
  • Lancellotti Pao. The EACVI Textbook of Echocardiography. The European Society of Cardiology Textbooks. Oxford University Press; 2016.
  • Schicchi N, Secinaro A, Muscogiuri G, et al. Multicenter review: role of cardiovascular magnetic resonance in diagnostic evaluation, pre-procedural planning and follow-up for patients with congenital heart disease. Radiol Med. 2016;121(5):342–351. doi:10.1007/s11547-015-0608-z
  • Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22(1):1–23; quiz 101–2. doi:10.1016/j.echo.2008.11.029
  • McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation. 2010;122(5):507–516. doi:10.1161/CIRCULATIONAHA.109.921692
  • Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005;112(8):1189–1197. doi:10.1161/CIRCULATIONAHA.104.523266
  • Ruckdeschel E, Kim YY. Pulmonary valve stenosis in the adult patient: pathophysiology, diagnosis and management. Heart. 2019;105(5):414–422. doi:10.1136/heartjnl-2017-312743
  • Lin Z, Chen Y, Zhou L, Chen S, Xia H. Serum N-Terminal Pro-B-Type natriuretic peptide as a biomarker of critical pulmonary stenosis in neonates. Front Pediatr. 2021;9:788715. doi:10.3389/fped.2021.788715
  • Duchnowski P. N-Terminal of the prohormone brain natriuretic peptide predicts postoperative cardiogenic shock requiring extracorporeal membrane oxygenation. J Clin Med. 2022;11:19.
  • Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019;32(1):1–64. doi:10.1016/j.echo.2018.06.004
  • Hahn RT, Saric M, Faletra FF, et al. Recommended standards for the performance of transesophageal echocardiographic screening for structural heart intervention: from the American Society of echocardiography. J Am Soc Echocardiogr. 2022;35(1):1–76. doi:10.1016/j.echo.2021.07.006
  • Lombardi Mao. The EACVI Textbook of Cardiovascular Magnetic Resonance. Lombardi Mao; 2018.
  • Kilner PJ, Manzara CC, Mohiaddin RH, et al. Magnetic resonance jet velocity mapping in mitral and aortic valve stenosis. Circulation. 1993;87(4):1239–1248. doi:10.1161/01.CIR.87.4.1239
  • Sondergaard L, Hildebrandt P, Lindvig K, et al. Valve area and cardiac output in aortic stenosis: quantification by magnetic resonance velocity mapping. Am Heart J. 1993;126(5):1156–1164. doi:10.1016/0002-8703(93)90669-Z
  • Myerson SG. CMR in evaluating valvular heart disease: diagnosis, severity, and outcomes. JACC Cardiovasc Imaging. 2021;14(10):2020–2032. doi:10.1016/j.jcmg.2020.09.029
  • Costantini P, Perone F, Siani A, et al. Multimodality imaging of the neglected valve: role of echocardiography, cardiac magnetic resonance and cardiac computed tomography in pulmonary stenosis and regurgitation. J Imaging. 2022;8(10):278. doi:10.3390/jimaging8100278
  • Kerl JM, Ravenel JG, Nguyen SA, et al. Right heart: split-bolus injection of diluted contrast medium for visualization at coronary CT angiography. Radiology. 2008;247(2):356–364. doi:10.1148/radiol.2472070856
  • Jonas SN, Kligerman SJ, Burke AP, Frazier AA, White CS. Pulmonary valve anatomy and abnormalities: a pictorial essay of radiography, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI). J Thorac Imaging. 2016;31(1):W4–12. doi:10.1097/RTI.0000000000000182
  • Rajiah P, Nazarian J, Vogelius E, Gilkeson RC. CT and MRI of pulmonary valvular abnormalities. Clin Radiol. 2014;69(6):630–638. doi:10.1016/j.crad.2014.01.019
  • Tops LF, Wood DA, Delgado V, et al. Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging. 2008;1(3):321–330. doi:10.1016/j.jcmg.2007.12.006
  • Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;143(5):e35–e71. doi:10.1161/CIR.0000000000000932
  • Nielsen EA, Hjortdal VE. Surgically treated pulmonary stenosis: over 50 years of follow-up. Cardiol Young. 2016;26(5):860–866. doi:10.1017/S1047951115001158
  • Kan JS, White RI Jr, Mitchell SE, Gardner TJ. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary-valve stenosis. N Engl J Med. 1982;307(9):540–542. doi:10.1056/NEJM198208263070907
  • Rao PS. Indications for balloon pulmonary valvuloplasty. Am Heart J. 1988;116(6 Pt 1):1661–1662. doi:10.1016/0002-8703(88)90790-9
  • Rao PS. Role of palliative balloon pulmonary valvuloplasty in babies with tetralogy of Fallot. Heart Vessels. 2020;35(11):1629–1630. doi:10.1007/s00380-020-01628-7
  • Merino-Ingelmo R, Santos-de Soto J, Coserria-Sanchez F, Descalzo-Senoran A, Valverde-Perez I. Long-term results of percutaneous balloon valvuloplasty in pulmonary valve stenosis in the pediatric population. Rev Esp Cardiol. 2014;67(5):374–379. doi:10.1016/j.recesp.2013.08.020
  • Rao PS. Percutaneous balloon pulmonary valvuloplasty: state of the art. Catheter Cardiovasc Interv. 2007;69(5):747–763. doi:10.1002/ccd.20982
  • Thapar MK, Rao PS. Significance of infundibular obstruction following balloon valvuloplasty for valvar pulmonic stenosis. Am Heart J. 1989;118(1):99–103. doi:10.1016/0002-8703(89)90078-1
  • Hong D, Qian MY, Zhang ZW, et al. Immediate therapeutic outcomes and medium-term follow-up of percutaneous balloon pulmonary valvuloplasty in infants with pulmonary valve stenosis: a single-center retrospective study. Chin Med J. 2017;130(23):2785–2792. doi:10.4103/0366-6999.219155
  • Hansen RL, Naimi I, Wang H, et al. Long-term outcomes up to 25 years following balloon pulmonary valvuloplasty: a multicenter study. Congenit Heart Dis. 2019;14(6):1037–1045. doi:10.1111/chd.12788
  • Sellors TH. Surgery of pulmonary stenosis; a case in which the pulmonary valve was successfully divided. Lancet. 1948;1(6513):988.
  • Brock SR. The Surgical Treatment of Pulmonary Stenosis. Br Heart J. 1961;23(4):337–356. doi:10.1136/hrt.23.4.337
  • Brock RC, Campbell M. Valvulotomy for pulmonary valvular stenosis. Br Heart J. 1950;12(4):377–402. doi:10.1136/hrt.12.4.377
  • S S, B PM, A AM. Outcomes 60 years after surgical valvotomy for isolated congenital pulmonary valve stenosis. J Card Surg. 2021;36(4):1531–1533. doi:10.1111/jocs.15276
  • Stanger P, Cassidy SC, Girod DA, Kan JS, Lababidi Z, Shapiro SR. Balloon pulmonary valvuloplasty: results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol. 1990;65(11):775–783. doi:10.1016/0002-9149(90)91387-L
  • DiSessa TG, Alpert BS, Chase NA, Birnbaum SE, Watson DC. Balloon valvuloplasty in children with dysplastic pulmonary valves. Am J Cardiol. 1987;60(4):405–407. doi:10.1016/0002-9149(87)90266-9
  • Kopecky SL, Gersh BJ, McGoon MD, et al. Long-term outcome of patients undergoing surgical repair of isolated pulmonary valve stenosis. Follow-up at 20–30 years. Circulation. 1988;78(5 Pt 1):1150–1156. doi:10.1161/01.CIR.78.5.1150
  • McNamara DG, Latson LA. Long-term follow-up of patients with malformations for which definitive surgical repair has been available for 25 years or more. Am J Cardiol. 1982;50(3):560–568. doi:10.1016/0002-9149(82)90325-3
  • Cuypers JA, Menting ME, Opić P, et al. The unnatural history of pulmonary stenosis up to 40 years after surgical repair. Heart. 2017;103(4):273–279. doi:10.1136/heartjnl-2015-309159
  • Roos-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Long-term outcome after surgery for pulmonary stenosis (a longitudinal study of 22–33 years). Eur Heart J. 2006;27(4):482–488. doi:10.1093/eurheartj/ehi685
  • P H, S MH, A RE, et al. A stented bovine pericardial prosthesis in the pulmonary position. J Thorac Cardiovasc Surg. 2020;159(3):1063–71.e1. doi:10.1016/j.jtcvs.2019.05.086
  • Kim DH, Choi ES, Kwon BS, et al. Pulmonary valve replacement following repair of tetralogy of Fallot: comparison of outcomes between bio- and mechanical prostheses. Europ J Cardio Thor Surg. 2021;60(4):947–954. doi:10.1093/ejcts/ezab099
  • Discigil B, Dearani JA, Puga FJ, et al. Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2001;121(2):344–351. doi:10.1067/mtc.2001.111209
  • Nomoto R, Sleeper LA, Borisuk MJ, et al. Outcome and performance of bioprosthetic pulmonary valve replacement in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2016;152(5):1333–42 e3. doi:10.1016/j.jtcvs.2016.06.064
  • Ferraz Cavalcanti PE, Sa MP, Santos CA, et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3118 patients from 48 studies. J Am Coll Cardiol. 2013;62(23):2227–2243. doi:10.1016/j.jacc.2013.04.107
  • Schubert SA, Myers JL, Kunselman AR, Clark JB. Early outcomes of pulmonary valve replacement with the mitroflow bovine pericardial bioprosthesis. Ann Thorac Surg. 2015;99(5):1692–1698. doi:10.1016/j.athoracsur.2014.12.081
  • Freling HG, van Slooten YJ, van Melle JP, et al. Pulmonary valve replacement: twenty-six years of experience with mechanical valvar prostheses. Ann Thorac Surg. 2015;99(3):905–910. doi:10.1016/j.athoracsur.2014.10.034
  • Asoh K, Walsh M, Hickey E, et al. Percutaneous pulmonary valve implantation within bioprosthetic valves. Eur Heart J. 2010;31(11):1404–1409. doi:10.1093/eurheartj/ehq056
  • Kwak JG, Bang JH, Cho S, et al. Long-term durability of bioprosthetic valves in pulmonary position: pericardial versus porcine valves. J Thorac Cardiovasc Surg. 2020;160(2):476–484. doi:10.1016/j.jtcvs.2019.11.134
  • Lee C, Park CS, Lee CH, et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2011;142(2):351–358. doi:10.1016/j.jtcvs.2010.12.020
  • Sabate Rotes A, Eidem BW, Connolly HM, et al. Long-term follow-up after pulmonary valve replacement in repaired tetralogy of Fallot. Am J Cardiol. 2014;114(6):901–908. doi:10.1016/j.amjcard.2014.06.023
  • Chen XJ, Smith PB, Jaggers J, Lodge AJ. Bioprosthetic pulmonary valve replacement: contemporary analysis of a large, single-center series of 170 cases. J Thorac Cardiovasc Surg. 2013;146(6):1461–1466. doi:10.1016/j.jtcvs.2012.09.081
  • Stulak JM, Dearani JA, Burkhart HM, et al. The increasing use of mechanical pulmonary valve replacement over a 40-year period. Ann Thorac Surg. 2010;90(6):2009–2014. doi:10.1016/j.athoracsur.2010.07.023
  • Shin HJ, Kim YH, Ko JK, Park IS, Seo DM. Outcomes of mechanical valves in the pulmonic position in patients with congenital heart disease over a 20-year period. Ann Thorac Surg. 2013;95(4):1367–1371. doi:10.1016/j.athoracsur.2012.07.008
  • Abbas JR, Hoschtitzky JA. Is there a role for mechanical valve prostheses in pulmonary valve replacement late after tetralogy of Fallot repair? Interact Cardiovasc Thorac Surg. 2014;18(5):661–666. doi:10.1093/icvts/ivt541
  • Pragt H, van Melle JP, Javadikasgari H, et al. Mechanical valves in the pulmonary position: an international retrospective analysis. J Thorac Cardiovasc Surg. 2017;154(4):1371–8 e1. doi:10.1016/j.jtcvs.2017.04.072
  • Lee C, Jacobs JP, Lee CH, Kwak JG, Chai PJ, Quintessenza JA. Surgical pulmonary valve insertion--when, how, and why. Cardiol Young. 2012;22(6):702–707. doi:10.1017/S1047951112001722
  • Alkashkari W, Alsubei A, Hijazi ZM. Transcatheter pulmonary valve replacement: current state of Art. Curr Cardiol Rep. 2018;20(4):27. doi:10.1007/s11886-018-0966-y
  • Ong K, Boone R, Gao M, et al. Right ventricle to pulmonary artery conduit reoperations in patients with tetralogy of fallot or pulmonary atresia associated with ventricular septal defect. Am J Cardiol. 2013;111(11):1638–1643. doi:10.1016/j.amjcard.2013.01.337
  • Boethig D, Thies WR, Hecker H, Breymann T. Mid term course after pediatric right ventricular outflow tract reconstruction: a comparison of homografts, porcine xenografts and Contegras. Eur J Cardiothorac Surg. 2005;27(1):58–66. doi:10.1016/j.ejcts.2004.09.009
  • Coats L, Tsang V, Khambadkone S, et al. The potential impact of percutaneous pulmonary valve stent implantation on right ventricular outflow tract re-intervention. Eur J Cardiothorac Surg. 2005;27(4):536–543. doi:10.1016/j.ejcts.2004.12.053
  • McElhinney DB, Hennesen JT. The Melody(R) valve and Ensemble(R) delivery system for transcatheter pulmonary valve replacement. Ann N Y Acad Sci. 2013;1291(1):77–85. doi:10.1111/nyas.12194
  • Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.s. Clinical trial. J Am Coll Cardiol. 2009;54(18):1722–1729. doi:10.1016/j.jacc.2009.06.034
  • Borik S, Crean A, Horlick E, et al. Percutaneous pulmonary valve implantation: 5 years of follow-up: does age influence outcomes? Circ Cardiovasc Interv. 2015;8(2):e001745. doi:10.1161/CIRCINTERVENTIONS.114.001745
  • Aboulhosn J, Levi DS. Percutaneous pulmonary valve implantation: is earlier valve implantation better? Circ Cardiovasc Interv. 2015;8(2):e002260. doi:10.1161/CIRCINTERVENTIONS.115.002260
  • Kenny D, Rhodes JF, Fleming GA, et al. 3-Year outcomes of the edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position from the COMPASSION multicenter clinical trial. JACC Cardiovasc Interv. 2018;11(19):1920–1929. doi:10.1016/j.jcin.2018.06.001
  • Faccini A, Giugno L, Piazza L, et al. Evolving technique for SAPIEN pulmonary valve implantation: a single-center experience. JACC Cardiovasc Interv. 2020;13(12):1500–1502. doi:10.1016/j.jcin.2020.02.039
  • Levi DS, Sinha S, Salem MM, Aboulhosn JA. Transcatheter native pulmonary valve and tricuspid valve replacement with the sapien XT: initial experience and development of a new delivery platform. Catheter Cardiovasc Interv. 2016;88(3):434–443. doi:10.1002/ccd.26398
  • DeGiovanni J. Transcatheter pulmonary valve replacement. The Edwards Sapien Valve. J Struct Heart Dis. 2017;3(3):62–72. doi:10.12945/j.jshd.2017.016.14
  • Hascoet S, Karsenty C, Tortigue M, et al. A modified procedure for percutaneous pulmonary valve implantation of the Edwards SAPIEN 3 valve. EuroIntervention. 2019;14(13):1386–1388. doi:10.4244/EIJ-D-18-00530
  • Morgan GJ, Sadeghi S, Salem MM, et al. SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without “pre-stenting”: a multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(2):324–329. doi:10.1002/ccd.27932
  • Shahanavaz S, Zahn EM, Levi DS, et al. Transcatheter pulmonary valve replacement with the sapien prosthesis. J Am Coll Cardiol. 2020;76(24):2847–2858. doi:10.1016/j.jacc.2020.10.041
  • Le Ruz R, Plessis J, Houeijeh A, et al. Edwards SAPIEN XT transcatheter pulmonary valve implantation: 5-year follow-up in a French Registry. Catheter Cardiovasc Interv. 2021;98(5):990–999. doi:10.1002/ccd.29862
  • Feltes TF, Bacha E, Beekman RH, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation. 2011;123(22):2607–2652. doi:10.1161/CIR.0b013e31821b1f10
  • Boshoff DE, Cools BL, Heying R, et al. Off-label use of percutaneous pulmonary valved stents in the right ventricular outflow tract: time to rewrite the label? Catheter Cardiovasc Interv. 2013;81(6):987–995. doi:10.1002/ccd.24594
  • Schievano S, Coats L, Migliavacca F, et al. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: implications for percutaneous pulmonary valve implantation. J Cardiovasc Magn Reson. 2007;9(4):687–695. doi:10.1080/10976640601187596
  • Boudjemline Y, Brugada G, Van-Aerschot I, et al. Outcomes and safety of transcatheter pulmonary valve replacement in patients with large patched right ventricular outflow tracts. Arch Cardiovasc Dis. 2012;105(8–9):404–413. doi:10.1016/j.acvd.2012.05.002
  • Schievano S, Taylor AM, Capelli C, et al. First-in-man implantation of a novel percutaneous valve: a new approach to medical device development. EuroIntervention. 2010;5(6):745–750. doi:10.4244/EIJV5I6A122
  • Cao QL, Kenny D, Zhou D, et al. Early clinical experience with a novel self-expanding percutaneous stent-valve in the native right ventricular outflow tract. Catheter Cardiovasc Interv. 2014;84(7):1131–1137. doi:10.1002/ccd.25544